{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:55:51Z","timestamp":1789008951029,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.00529","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T04:31:16Z","timestamp":1600144276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["In vivo Imaging With 18F-FDG- and 18F-Florbetaben-PET\/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer's Disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Timon N.","family":"Franke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Beindorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Bouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"B1","unstructured":"LondonAlzheimer's Disease InternationalWorld Alzheimer Report 2018\u2014The State of the Art Dementia Research: New frontiers2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol Neurodegener."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","article-title":"The diagnostic value of FDG and amyloid PET in Alzheimer's disease-a systematic review","volume":"94","author":"Rice","year":"2017","journal-title":"Eur J Radiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.nicl.2016.11.025","article-title":"Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry","volume":"13","author":"Sorensen","year":"2017","journal-title":"Neuroimage Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","article-title":"Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model","volume":"33","author":"Kimura","year":"2009","journal-title":"Neurobiol Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"196 e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation","volume":"8","author":"Eimer","year":"2013","journal-title":"Mol Neurodegener."},{"key":"B10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.neurobiolaging.2012.12.027","article-title":"In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography","volume":"34","author":"Rojas","year":"2013","journal-title":"Neurobiol Aging."},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2174\/1567205011666140505111354","article-title":"Early detection of cerebral glucose uptake changes in the 5XFAD mouse","volume":"11","author":"Macdonald","year":"2014","journal-title":"Curr Alzheimer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5272014","DOI":"10.1155\/2018\/5272014","article-title":"Early detection of abeta deposition in the 5xFAD mouse by amyloid PET","volume":"2018","author":"Oh","year":"2018","journal-title":"Contrast Media Mol Imaging."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2967\/jnumed.112.114660","article-title":"Longitudinal assessment of cerebral beta-amyloid deposition in mice overexpressing Swedish mutant beta-amyloid precursor protein using 18F-florbetaben PET","volume":"54","author":"Rominger","year":"2013","journal-title":"J Nucl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","article-title":"(18)F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer's disease","volume":"10","author":"Bouter","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods."},{"key":"B17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00401-013-1129-2","article-title":"N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits","volume":"126","author":"Bouter","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnbeh.2019.00094","article-title":"Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57BL\/6J mice","volume":"13","author":"Schleicher","year":"2019","journal-title":"Front Behav Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","article-title":"Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against Ntruncated Abeta in sporadic Alzheimer disease cases and mouse models","volume":"130","author":"Bouter","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0971-6203.25665","article-title":"Positron emission tomography: An overview","volume":"31","author":"Shukla","year":"2006","journal-title":"J Med Phys."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12149-009-0330-9","article-title":"Amyloid-plaque imaging in early and differential diagnosis of dementia","volume":"24","author":"Drzezga","year":"2010","journal-title":"Ann Nucl Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imaging."},{"key":"B24","doi-asserted-by":"publisher","first-page":"CD010632","DOI":"10.1002\/14651858.CD010632.pub2","article-title":"(1)(8)F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"1","author":"Smailagic","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/RLU.0000000000000934","article-title":"Amyloid imaging with 11C-PIB in patients with cognitive impairment in a clinical setting: a visual and semiquantitative analysis","volume":"41","author":"Jimenez-Bonilla","year":"2016","journal-title":"Clin Nucl Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-3-7091-0932-8_25","article-title":"Synaptic dysfunction in Alzheimer's disease","volume":"970","author":"Marcello","year":"2012","journal-title":"Adv Exp Med Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fnins.2019.00735","article-title":"Targeting the synapse in Alzheimer's disease","volume":"13","author":"Jackson","year":"2019","journal-title":"Front Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"833 e839","DOI":"10.1016\/j.neurobiolaging.2011.08.006","article-title":"No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Hillmann","year":"2012","journal-title":"Neurobiol Aging."},{"key":"B29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnbeh.2018.00273","article-title":"Effects of a dehydroevodiamine-derivative on synaptic destabilization and memory impairment in the 5xFAD, Alzheimer's disease mouse model","volume":"12","author":"Kang","year":"2018","journal-title":"Front Behav Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2017.12.028","article-title":"The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease","volume":"1702","author":"Braun","year":"2019","journal-title":"Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fphar.2019.01391","article-title":"Bazhu decoction, a traditional chinese medical formula, ameliorates cognitive deficits in the 5xFAD mouse model of Alzheimer's disease","volume":"10","author":"Peng","year":"2019","journal-title":"Front Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J Biol Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2013.09.016","article-title":"Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice","volume":"254","author":"Buskila","year":"2013","journal-title":"Neuroscience."},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fmed.2019.00071","article-title":"(18)F-FDG-PET in mouse models of Alzheimer's disease","volume":"6","author":"Bouter","year":"2019","journal-title":"Front Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.arr.2016.02.003","article-title":"Brain fluorodeoxyglucose (FDG) PET in dementia","volume":"30","author":"Kato","year":"2016","journal-title":"Ageing Res Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02988596","article-title":"Cerebral blood flow and metabolic abnormalities in Alzheimer's disease","volume":"15","author":"Matsuda","year":"2001","journal-title":"Ann Nucl Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/brain\/awp253","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/WCO.0000000000000570","article-title":"Alzheimer's disease neuroimaging","volume":"31","author":"Whitwell","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.4103\/0366-6999.162507","article-title":"Reduction of glucose metabolism in olfactory bulb is an earlier Alzheimer's disease-related biomarker in 5XFAD mice","volume":"128","author":"Xiao","year":"2015","journal-title":"Chin Med J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1536012117704557","DOI":"10.1177\/1536012117704557","article-title":"Brain and brown adipose tissue metabolism in transgenic Tg2576 mice models of Alzheimer disease assessed using (18)F-FDG PET imaging","volume":"16","author":"Coleman","year":"2017","journal-title":"Mol Imaging."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1177\/0271678X16677990","article-title":"Brain energy metabolism and neuroinflammation in ageing APP\/PS1-21 mice using longitudinal (18)F-FDG and (18)F-DPA-714 PET imaging","volume":"37","author":"Takkinen","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3233\/JAD-160760","article-title":"Longitudinal characterization of [18F]-FDG and [18F]-AV45 uptake in the double transgenic TASTPM mouse model","volume":"55","author":"Waldron","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","article-title":"Brain PET in the diagnosis of Alzheimer's disease","volume":"39","author":"Marcus","year":"2014","journal-title":"Clin Nucl Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","article-title":"Energy metabolism and inflammation in brain aging and Alzheimer's disease","volume":"100","author":"Yin","year":"2016","journal-title":"Free Radic Biol Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B47","doi-asserted-by":"publisher","first-page":"624919","DOI":"10.1177\/1536012115624919","article-title":"The effects of physiological and methodological determinants on 18F-FDG mouse brain imaging exemplified in a double transgenic Alzheimer model","volume":"15","author":"Deleye","year":"2016","journal-title":"Mol Imaging."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.neurobiolaging.2011.09.026","article-title":"Increased regional cerebral glucose uptake in an APP\/PS1 model of Alzheimer's disease","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol Aging."},{"key":"B49","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2967\/jnumed.115.167858","article-title":"Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study","volume":"57","author":"Brendel","year":"2016","journal-title":"J Nucl Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.3390\/ijms17101707","article-title":"Age- and brain region-specific changes of glucose metabolic disorder, learning, and memory dysfunction in early Alzheimer's disease assessed in APP\/PS1 transgenic mice using (18)F-FDG-PET","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2967\/jnumed.110.085092","article-title":"Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice","volume":"52","author":"Wong","year":"2011","journal-title":"J Nucl Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"CD012884","DOI":"10.1002\/14651858.CD012884","article-title":"18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"11","author":"Martinez","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"20065","DOI":"10.3390\/diagnostics9020065","article-title":"The who, when, why, and how of PET amyloid imaging in management of Alzheimer's disease-review of literature and interesting images","volume":"9","author":"Suppiah","year":"2019","journal-title":"Diagnostics."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","article-title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain","volume":"25","author":"Klunk","year":"2005","journal-title":"J Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11307-009-0198-z","article-title":"Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease","volume":"11","author":"Kuntner","year":"2009","journal-title":"Mol Imaging Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0116678","DOI":"10.1371\/journal.pone.0116678","article-title":"Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models","volume":"10","author":"Brendel","year":"2015","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e31310","DOI":"10.1371\/journal.pone.0031310","article-title":"Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP\/PS1 mouse model of Alzheimer's disease","volume":"7","author":"Manook","year":"2012","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12868-018-0447-7","article-title":"Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents (18)F-flutemetamol and (18)F-florbetaben","volume":"19","author":"Son","year":"2018","journal-title":"BMC Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","article-title":"Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography","volume":"27","author":"Maeda","year":"2007","journal-title":"J Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/mp.2015.74","article-title":"Amyloid-PET predicts inhibition of de novo plaque formation upon chronic gamma-secretase modulator treatment","volume":"20","author":"Brendel","year":"2015","journal-title":"Mol Psychiatry."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.7150\/thno.27868","article-title":"Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Abeta deposition rate and plaque burden at treatment initiation","volume":"8","author":"Brendel","year":"2018","journal-title":"Theranostics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-143120","article-title":"Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer's disease","volume":"45","author":"Richard","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1088\/0031-9155\/54\/9\/020","article-title":"Performance evaluation of an Inveon PET preclinical scanner","volume":"54","author":"Constantinescu","year":"2009","journal-title":"Phys Med Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2010.08.005","article-title":"Characterization of 7- and 19-months-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease","volume":"33","author":"Luo","year":"2012","journal-title":"Neurobiol Aging."},{"key":"B65","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2967\/jnumed.112.119065","article-title":"Performance evaluation of the small-animal nanoScan PET\/MRI system","volume":"54","author":"Nagy","year":"2013","journal-title":"J Nucl Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T04:31:19Z","timestamp":1600144279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.00529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":65,"alternative-id":["10.3389\/fmed.2020.00529"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.00529","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"article-number":"529"}}